• Study on the Effects of ATL1102 for Nonambulatory Patients with Duchenne Muscular Dystrophy

    Not recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria

  • Access to Mepolizumab for Patients with Hypereosinophilic Syndrome

    Not recruiting

    3 1 1
    Investigated Drugs:
    Poland

  • Study of Visugromab and Nivolumab for Patients with Muscle-Invasive Bladder Cancer Who Cannot or Refuse Cisplatin Chemotherapy

    Not recruiting

    2 1 1
    Investigated Drugs:
    Italy

  • Study on Itacitinib for Treating Non-Severe Hemophagocytic Lymphohistiocytosis in Adults

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    France

  • Study comparing iberdomide, daratumumab and dexamethasone versus daratumumab, bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Czechia Denmark Finland France +10

  • Study on the Effects of Mitapivat for Patients with Transfusion-Dependent Alpha or Beta Thalassemia

    Not recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria Denmark France Germany Greece Italy +2

  • Study on Emicizumab for Patients with Mild or Moderate Hemophilia A Without FVIII Inhibitors

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Belgium France Germany

  • Study on the Effectiveness and Safety of Cariprazine for Adolescents (13-17 years) with Schizophrenia

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria Romania

  • Study on Personalized Dosing of Natalizumab for Patients with Relapsing-Remitting Multiple Sclerosis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands

  • Study on Itacitinib for Adults with Diffuse Systemic Sclerosis

    Not recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    France

powered by